28233467|t|Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease
28233467|a|Mitochondrial disease (MD) is a genetic disorder affecting skeletal muscles, with possible myocardial disease. The ergoreflex, sensitive to skeletal muscle work, regulates ventilatory and autonomic responses to exercise. We hypothesized the presence of an increased ergoreflex sensitivity in MD patients, its association with abnormal ventilatory and autonomic responses, and possibly with subclinical cardiac involvement. Twenty-five MD patients (aged 46 Â± 3 years, 32% male) with skeletal myopathy but without known cardiac disease, underwent a thorough evaluation including BNPs, galectin-3, soluble suppression of tumorigenesis 2 (sST2), high sensitivity troponin T/I, catecholamines, ECG, 24-h ECG recording, cardiopulmonary exercise testing, echocardiography, cardiac/muscle magnetic resonance (C/MMR), and ergoreflex assessment. Thirteen age- and sex-matched healthy controls were chosen. Among these myopathic patients, subclinical cardiac damage was detected in up to 80%, with 44% showing fibrosis at CMR. Ergoreflex sensitivity was markedly higher in patients than in controls (64% vs. 37%, P < 0.001), and correlated with muscle fat to water ratio and extracellular volume at MMR (both P < 0.05). Among patients, ergoreflex sensitivity was higher in those with cardiac involvement (P = 0.034). Patients showed a lower peak oxygen consumption (VO2 /kg) than controls (P < 0.001), as well as ventilatory inefficiency (P = 0.024). Ergoreflex sensitivity correlated with reduced workload and peak VO2 /kg (both P < 0.001), and several indicators of autonomic imbalance (P < 0.05). Plasma norepinephrine was the unique predictor of myocardial fibrosis at univariate analysis (P < 0.05). Skeletal myopathy in MD is characterized by enhanced ergoreflex sensitivity, which is associated with a higher incidence of cardiac involvement, exercise intolerance, and sympathetic activation.
28233467	0	9	Autonomic	T033	C1837624
28233467	11	21	functional	T190	C0302142
28233467	23	38	skeletal muscle	T190	C0302142
28233467	44	65	cardiac abnormalities	T019	C0018798
28233467	70	85	associated with	T080	C0332281
28233467	86	95	increased	T081	C0205217
28233467	96	118	ergoreflex sensitivity	T033	C0243095
28233467	122	143	mitochondrial disease	T047	C0751651
28233467	144	165	Mitochondrial disease	T047	C0751651
28233467	167	169	MD	T047	C0751651
28233467	176	192	genetic disorder	T047	C0019247
28233467	203	219	skeletal muscles	T024	C0242692
28233467	235	253	myocardial disease	T047	C0878544
28233467	259	269	ergoreflex	T042	C0034929
28233467	284	299	skeletal muscle	T024	C0242692
28233467	300	304	work	T042	C1254358
28233467	306	315	regulates	T038	C1327622
28233467	316	327	ventilatory	T201	C1321070
28233467	332	351	autonomic responses	T042	C1254358
28233467	355	363	exercise	T056	C0015259
28233467	400	409	increased	T081	C0205217
28233467	410	432	ergoreflex sensitivity	T033	C0243095
28233467	436	438	MD	T047	C0751651
28233467	439	447	patients	T101	C0030705
28233467	453	469	association with	T080	C0332281
28233467	470	478	abnormal	T033	C0205161
28233467	479	490	ventilatory	T201	C1321070
28233467	495	514	autonomic responses	T042	C1254358
28233467	534	565	subclinical cardiac involvement	T033	C0243095
28233467	579	581	MD	T047	C0751651
28233467	582	590	patients	T101	C0030705
28233467	604	609	years	T079	C1510829
28233467	615	619	male	T098	C0025266
28233467	626	643	skeletal myopathy	T047	C1533847
28233467	662	677	cardiac disease	T047	C0018799
28233467	700	710	evaluation	T058	C0220825
28233467	721	725	BNPs	T059	C1095989
28233467	727	737	galectin-3	T059	C3496493
28233467	739	758	soluble suppression	T059	C0201782
28233467	762	777	tumorigenesis 2	T191	C0007621
28233467	779	783	sST2	T059	C0201782
28233467	786	790	high	T080	C0205250
28233467	791	802	sensitivity	T081	C0392762
28233467	803	815	troponin T/I	T059	C0523952
28233467	817	831	catecholamines	T059	C0546632
28233467	833	836	ECG	T033	C0013798
28233467	838	856	24-h ECG recording	T033	C0013798
28233467	858	890	cardiopulmonary exercise testing	T060	C2959886
28233467	892	908	echocardiography	T060	C0013516
28233467	910	943	cardiac/muscle magnetic resonance	T060	C0024485
28233467	945	950	C/MMR	T060	C0024485
28233467	957	978	ergoreflex assessment	T058	C0220825
28233467	989	1026	age- and sex-matched healthy controls	T080	C2986479
28233467	1052	1061	myopathic	T047	C0026848
28233467	1062	1070	patients	T101	C0030705
28233467	1072	1098	subclinical cardiac damage	T033	C0243095
28233467	1103	1111	detected	T033	C0442726
28233467	1143	1151	fibrosis	T046	C0016059
28233467	1155	1158	CMR	T060	C0024485
28233467	1160	1182	Ergoreflex sensitivity	T033	C0243095
28233467	1206	1214	patients	T101	C0030705
28233467	1223	1231	controls	T096	C0009932
28233467	1278	1303	muscle fat to water ratio	T081	C0392762
28233467	1308	1321	extracellular	T026	C0521119
28233467	1322	1328	volume	T081	C0449468
28233467	1332	1335	MMR	T060	C0024485
28233467	1359	1367	patients	T101	C0030705
28233467	1369	1391	ergoreflex sensitivity	T033	C0243095
28233467	1417	1436	cardiac involvement	T033	C0243095
28233467	1450	1458	Patients	T101	C0030705
28233467	1479	1497	oxygen consumption	T201	C0030055
28233467	1499	1502	VO2	T201	C0030055
28233467	1513	1521	controls	T096	C0009932
28233467	1546	1570	ventilatory inefficiency	T033	C3540840
28233467	1584	1606	Ergoreflex sensitivity	T033	C0243095
28233467	1631	1639	workload	T081	C0085122
28233467	1649	1652	VO2	T201	C0030055
28233467	1679	1686	several	T081	C0443302
28233467	1687	1697	indicators	T081	C0392762
28233467	1701	1720	autonomic imbalance	T047	C0262385
28233467	1733	1739	Plasma	T031	C0032105
28233467	1740	1754	norepinephrine	T109,T121,T125	C0028351
28233467	1770	1779	predictor	T078	C2698872
28233467	1783	1802	myocardial fibrosis	T046	C0151654
28233467	1806	1825	univariate analysis	T062	C0683962
28233467	1838	1855	Skeletal myopathy	T047	C1533847
28233467	1859	1861	MD	T047	C0751651
28233467	1891	1913	ergoreflex sensitivity	T033	C0243095
28233467	1924	1939	associated with	T080	C0332281
28233467	1949	1958	incidence	T081	C0021149
28233467	1962	1981	cardiac involvement	T033	C0243095
28233467	1983	2003	exercise intolerance	T033	C0424551
28233467	2009	2031	sympathetic activation	T039	C1254359